| __timestamp | Alpine Immune Sciences, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 79696000 |
| Thursday, January 1, 2015 | 16054000 | 93236000 |
| Friday, January 1, 2016 | 23316000 | 150842000 |
| Sunday, January 1, 2017 | 10626000 | 150643000 |
| Monday, January 1, 2018 | 28970000 | 150252000 |
| Tuesday, January 1, 2019 | 35847000 | 140804000 |
| Wednesday, January 1, 2020 | 27185000 | 34236000 |
| Friday, January 1, 2021 | 58742000 | 35672000 |
| Saturday, January 1, 2022 | 70243000 | 66607000 |
| Sunday, January 1, 2023 | 80904000 | 76363000 |
| Monday, January 1, 2024 | 79048000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Halozyme Therapeutics, Inc. and Alpine Immune Sciences, Inc. have demonstrated contrasting R&D investment strategies. From 2014 to 2023, Halozyme consistently outspent Alpine, with its R&D expenses peaking in 2016 at nearly double Alpine's highest expenditure. However, Alpine has shown a remarkable growth trajectory, increasing its R&D spending by over 560% from 2014 to 2023. This surge reflects Alpine's aggressive push towards groundbreaking therapies. Meanwhile, Halozyme's R&D spending saw a significant dip post-2018, aligning with its strategic shift towards commercialization. As the biotech landscape evolves, these spending patterns offer a glimpse into each company's future direction and potential impact on the industry.
Novo Nordisk A/S vs Halozyme Therapeutics, Inc.: Strategic Focus on R&D Spending
GSK plc or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.